Stockreport

Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd. To Develop And Commercialize New Chemical Entity For Psoriasis

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com